Decreased level of miR-1301 promotes colorectal cancer progression via activation of STAT3 pathway
Author:
Yang Fangfang12, Wang Hua12, Yan Bianbian12, Li Tong12, Min Lulu12, Chen Erfei12, Yang Jin12ORCID
Affiliation:
1. Institute of Preventive Genomic Medicine, School of Life Sciences, Northwest University , Xi’an 710069 , China 2. Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Life Sciences, Northwest University , Xi’an 710069 , China
Abstract
Abstract
The molecular pathogenesis of colorectal cancer (CRC) has been widely investigated in recent years. Accumulating evidence has indicated that microRNA (miRNA) dysregulation participates in the processes of driving CRC initiation and progression. Aberrant expression of miR-1301 has been found in various tumor types. However, its role in CRC remains to be elucidated. In the present study, we identified miR-1301 was enriched in normal colorectal tissues and significantly down-regulated in CRC. Decreased level of miR-1301 strongly correlated with aggressive pathological characteristics, including advanced stage and metastasis. Bioinformatics and dual luciferase assay demonstrated that STAT3 is a direct target of miR-1301. Gain and loss-of-function assays showed that miR-1301 had no effect on cell proliferation. Overexpression of miR-1301 suppressed cell migration and invasion capacity of pSTAT3-positive LoVo cells, but not pSTAT3-negative SW480 cells, while inhibition of miR-1301 consistently promoted cell migration and invasion in both cell lines. Additionally, miR-1301 inhibition restored the suppressed migration and invasion of STAT3-knockdown LoVo cells. MiR-1301 functioned as a tumor suppressor to modulate the IL6/STAT3 signaling pathway. In summary, this study highlights the significant role of miR-1301/STAT3 axis in CRC metastasis.
Publisher
Walter de Gruyter GmbH
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference27 articles.
1. Arndt, G.M., Dossey, L., Cullen, L.M., Lai, A., Druker, R., Eisbacher, M., Zhang, C., Tran, N., Fan, H., Retzlaff, K., Bittner, A., and Raponi, M. (2009). Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Canc. 9: 374, https://doi.org/10.1186/1471-2407-9-374. 2. Bi, D., Ning, H., Liu, S., Que, X., and Ding, K. (2016). miR-1301 promotes prostate cancer proliferation through directly targeting PPP2R2C. Biomed. Pharmacother. 81: 25–30, https://doi.org/10.1016/j.biopha.2016.03.043. 3. Chen, D.L., Wang, Z.Q., Zeng, Z.L., Wu, W.J., Zhang, D.S., Luo, H.Y., Wang, F., Qiu, M.Z., Wang, D.S., Ren, C., et al.. (2014). Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression. Hepatology 60: 598–609, https://doi.org/10.1002/hep.27118. 4. Chang, Y.C., Su, C.Y., Chen, M.H., Chen, W.S., Chen, C.L., and Hsiao, M. (2017). Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosis. Mol. Canc. 16: 135, https://doi.org/10.1186/s12943-017-0687-7. 5. Chen, E., Li, Q., Wang, H., Yang, F., Min, L., and Yang, J. (2018a). MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study. Biomed. Pharmacother. 106: 1370–1377, https://doi.org/10.1016/j.biopha.2018.07.098.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|